Edition:
United States

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

22.39USD
26 Apr 2018
Change (% chg)

$0.45 (+2.05%)
Prev Close
$21.94
Open
$22.01
Day's High
$22.85
Day's Low
$21.71
Volume
195,582
Avg. Vol
197,907
52-wk High
$27.73
52-wk Low
$14.24

Select another date:

Mon, Feb 26 2018

BRIEF-Diplomat Pharmacy Posts Q4 Adj. Earnings Per Share $0.18

* DIPLOMAT ANNOUNCES 4TH QUARTER AND 2017 YEAR END FINANCIAL RESULTS; PROVIDES 2018 GUIDANCE

BRIEF-Diplomat Pharmacy Says Dispensing Advanced Kidney Treatment, CABOMETYX

* DIPLOMAT PHARMACY INC - ‍IS DISPENSING EXELIXIS' LIMITED-DISTRIBUTION TREATMENT CABOMETYX NOW WITH AN EXPANDED INDICATION​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook

* DIPLOMAT PHARMACY INC - ‍JEFF PARK, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY​

BRIEF-Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook

* - EXPECTS 2017 REVENUE TO BE NEAR MIDDLE OF PREVIOUSLY PROVIDED RANGE

BRIEF-Diplomat Completes Acquisition Of LDI Integrated Pharmacy Services

* DIPLOMAT COMPLETES ACQUISITION OF LDI INTEGRATED PHARMACY SERVICES, SECURES NEW CREDIT FACILITIES

BRIEF-Diplomat Adds Chris Luthin As Executive Vice President

* DIPLOMAT ADDS CHRIS LUTHIN AS EXECUTIVE VICE PRESIDENT Source text for Eikon: Further company coverage:

Diplomat Pharmacy plunges as investors fret over rapid PBM push

Shares of Diplomat Pharmacy Inc tumbled 20 percent on Thursday after the company acquired a second pharmacy benefit manager in less than a month, sparking concerns it is expanding into a business that is under heightened regulatory scrutiny.

Diplomat Pharmacy plunges as investors fret over rapid PBM push

Nov 16 Shares of Diplomat Pharmacy Inc tumbled 20 percent on Thursday after the company acquired a second pharmacy benefit manager in less than a month, sparking concerns it is expanding into a business that is under heightened regulatory scrutiny.

BRIEF-Diplomat to acquire LDI Integrated Pharmacy Services

* Diplomat Pharmacy Inc - ‍will pay LDI $515 million cash and approximately $80 million in diplomat common stock​

BRIEF-Diplomat to acquire National Pharmaceutical Services

* Diplomat to acquire National Pharmaceutical Services Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Select another date: